טוען...
Tumor Restrictions to Oncolytic Virus
Oncolytic virotherapy has advanced since the days of its conception but therapeutic efficacy in the clinics does not seem to reach the same level as in animal models. One reason is premature oncolytic virus clearance in humans, which is a reasonable assumption considering the immune-stimulating natu...
שמור ב:
| הוצא לאור ב: | Biomedicines |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5423468/ https://ncbi.nlm.nih.gov/pubmed/28548066 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines2020163 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|